Marijuana use and treatment outcome among opioid-dependent patients

被引:42
作者
Budney, AJ
Bickel, WK
Amass, L
机构
[1] Univ Vermont, Dept Psychiat, S Burlington, VT 05403 USA
[2] Univ Vermont, Dept Psychol, S Burlington, VT 05403 USA
关键词
D O I
10.1046/j.1360-0443.1998.9344935.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims. Information concerning the association between marijuana use and opioid dependence and its treatment is needed to determine effective clinical guidelines for addressing marijuana use among opioid abusers. Setting and participants. Marijuana use was assessed in 107 people enrolled in treatment for opioid dependence. Design and measurement. Univariate comparisons of marijuana users and non-users and multivariate regression analyses were performed to examine associations between marijuana use and socio-demographic, psychosocial, medical and substance-use variables. The relationship between marijuana use and treatment outcome was also explored in a subset of this sample who received treatment that included buprenorphine detoxification and behavior therapy (N = 79). Findings. Sixty-sh per cent of participants were current marijuana users and almost all (94%) continued to use during treatment. Users were less likely to be married than non-users, and more likely to report financial difficulties, be involved in drug dealing and engage in sharing of needles (p < 0.05). A unique effect of marijuana use on drug dealing and sharing needles was retained after statistically controlling for the influence of heroin and alcohol use and other socio-demographic variables. No significant adverse relations were observed between marijuana use and treatment outcome. Conclusion. Pending a more comprehensive understanding of the function and consequences of marijuana use on psychosocial functioning, it appears that progress in treatment for opioid dependence can be made without mandating that patients abstain from marijuana use.
引用
收藏
页码:493 / 503
页数:11
相关论文
共 31 条
  • [1] ALTERNATE-DAY DOSING DURING BUPRENORPHINE TREATMENT OF OPIOID DEPENDENCE
    AMASS, L
    BICKEL, WK
    HIGGINS, ST
    BADGER, GJ
    [J]. LIFE SCIENCES, 1994, 54 (17) : 1215 - 1228
  • [2] [Anonymous], 1993, Am. J. Addict
  • [3] Ball J, 1988, NIDA Res Monogr, V81, P224
  • [4] Ball J.C., 1991, EFFECTIVENESS METHAD
  • [5] AN INVENTORY FOR MEASURING DEPRESSION
    BECK, AT
    ERBAUGH, J
    WARD, CH
    MOCK, J
    MENDELSOHN, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) : 561 - &
  • [6] Buprenorphine Treatment of Opioid Dependence: A Review
    Bickel, Warren K.
    Amass, Leslie
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1995, 3 (04) : 477 - 489
  • [7] THE TREATMENT OF ALCOHOLIC METHADONE PATIENTS - A REVIEW
    BICKEL, WK
    MARION, I
    LOWINSON, JH
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1987, 4 (01) : 15 - 19
  • [8] THE RELATIONSHIP OF MEAN DAILY BLOOD-ALCOHOL LEVELS TO ADMISSION MAST, CLINIC ABSENTEEISM AND DEPRESSION IN ALCOHOLIC METHADONE PATIENTS
    BICKEL, WK
    AMASS, L
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1993, 32 (02) : 113 - 118
  • [9] THE BEHAVIORAL ECONOMICS OF CONCURRENT DRUG REINFORCERS - A REVIEW AND REANALYSIS OF DRUG SELF-ADMINISTRATION RESEARCH
    BICKEL, WK
    DEGRANDPRE, RJ
    HIGGINS, ST
    [J]. PSYCHOPHARMACOLOGY, 1995, 118 (03) : 250 - 259
  • [10] Effects of adding behavioral treatment to opioid detoxification with buprenorphine
    Bickel, WK
    Amass, L
    Higgins, ST
    Badger, GJ
    Esch, RA
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1997, 65 (05) : 803 - 810